Portrait of Joanna Phillips
ucsf logo

Joanna Phillips, MD

Anatomic Pathology • Neuropathology
Portrait of Joanna Phillips
Portrait of Joanna Phillips
ucsf logo

Joanna Phillips, MD

Anatomic Pathology • Neuropathology

On this page

About me

Dr. Joanna Phillips is a neuropathologist, specializing in the examination of central nervous system tissue to help diagnose neurological diseases. Her particular goal is to improve brain tumor treatment through both patient care and research.

Phillips' research focuses on understanding how invading tumor cells interact with the components of the brain tumor microenvironment (the biological components immediately surrounding the tumor), and how these key interactions influence the development of a glioma (a type of brain tumor) and its response to therapy.

Phillips earned her medical degree and doctorate at the University of Pennsylvania's Perelman School of Medicine. She completed a pathology residency at the University of Washington, followed by a fellowship in neuropathology at UCSF.

Phillips is a member of several professional organizations, including the American Society for Investigative Pathology, American Association of Neuropathologists, American Association for Cancer Research, and Glycobiology Research and Training Program.

Education & training

Board certification

  • Anatomic Pathology, American Board of Pathology
  • Neuropathology, American Board of Pathology

Fellowship

  • Neuropathology, University of CA at San Francisco - Pathology GME

Residency

  • Anatomic/Clinical Pathology, University of Washington School of Medicine GME

Degree

  • MD, University of Pennsylvania School of Medicine

My expertise

My research

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.